Alumis Inc.

ALMS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025
Revenue $24.1M
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $386.0M
SG&A Expense $91.9M
Operating Income $-453.8M
Operating Margin -1,886.9%
Interest Expense
Pretax Income $-251.9M
Income Tax Expense $-8.6M
Net Income $-243.3M
Net Margin -1,011.7%
EPS (Basic) $-2.86
EPS (Diluted) $-2.86
Shares Outstanding (Basic) 85.0M
Shares Outstanding (Diluted) 85.0M
Dividends Per Share